First United Bank & Trust Abbott Laboratories Transaction History

First United Bank & Trust

  • $272 Million
  • Q3 2024

A detailed history of First United Bank & Trust transactions in Abbott Laboratories stock. As of the latest transaction made, First United Bank & Trust holds 16,174 shares of ABT stock, worth $1.86 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
16,174
Previous 16,821 3.85%
Holding current value
$1.86 Million
Previous $1.75 Million 5.5%
% of portfolio
0.68%
Previous 0.67%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024
SELL
$100.07 - $118.13 $64,745 - $76,430
-647 Reduced 3.85%
16,174 $1.84 Million
Q2 2024

Aug 12, 2024
SELL
$100.73 - $112.44 $29,715 - $33,169
-295 Reduced 1.72%
16,821 $1.75 Million
Q1 2024

Apr 29, 2024
SELL
$109.52 - $120.96 $16,756 - $18,506
-153 Reduced 0.89%
17,116 $1.95 Million
Q4 2023

Feb 07, 2024
SELL
$90.19 - $110.4 $48,792 - $59,726
-541 Reduced 3.04%
17,269 $1.9 Million
Q3 2023

Oct 24, 2023
SELL
$95.53 - $114.62 $32,193 - $38,626
-337 Reduced 1.86%
17,810 $1.72 Million
Q2 2023

Jul 13, 2023
SELL
$100.78 - $112.29 $17,334 - $19,313
-172 Reduced 0.94%
18,147 $1.98 Million
Q1 2023

Apr 18, 2023
SELL
$96.86 - $114.01 $21,115 - $24,854
-218 Reduced 1.18%
18,319 $1.85 Million
Q4 2022

Jan 19, 2023
SELL
$95.06 - $111.52 $19,962 - $23,419
-210 Reduced 1.12%
18,537 $0
Q3 2022

Oct 25, 2022
SELL
$96.76 - $112.03 $33,382 - $38,650
-345 Reduced 1.81%
18,747 $1.81 Million
Q2 2022

Jul 18, 2022
BUY
$102.07 - $123.37 $121,463 - $146,810
1,190 Added 6.65%
19,092 $2.07 Million
Q1 2022

Apr 20, 2022
SELL
$114.02 - $139.04 $74,113 - $90,376
-650 Reduced 3.5%
17,902 $2.12 Million
Q4 2021

Jan 20, 2022
SELL
$115.53 - $141.46 $20,910 - $25,604
-181 Reduced 0.97%
18,552 $2.61 Million
Q3 2021

Oct 14, 2021
BUY
$116.66 - $129.06 $1,516 - $1,677
13 Added 0.07%
18,733 $2.21 Million
Q2 2021

Jul 19, 2021
SELL
$105.79 - $124.53 $81,987 - $96,510
-775 Reduced 3.98%
18,720 $2.17 Million
Q1 2021

Apr 20, 2021
SELL
$108.84 - $128.23 $72,052 - $84,888
-662 Reduced 3.28%
19,495 $2.34 Million
Q4 2020

Jan 19, 2021
SELL
$105.0 - $114.42 $43,155 - $47,026
-411 Reduced 2.0%
20,157 $2.21 Million
Q3 2020

Oct 13, 2020
BUY
$91.64 - $111.29 $3,665 - $4,451
40 Added 0.19%
20,568 $2.24 Million
Q2 2020

Jul 14, 2020
BUY
$76.57 - $98.0 $15,313 - $19,600
200 Added 0.98%
20,528 $1.88 Million
Q1 2020

Apr 13, 2020
BUY
$62.82 - $91.86 $5,025 - $7,348
80 Added 0.4%
20,328 $1.6 Million
Q4 2019

Jan 13, 2020
BUY
$78.51 - $87.4 $35,329 - $39,330
450 Added 2.27%
20,248 $1.76 Million
Q3 2019

Oct 11, 2019
SELL
$81.84 - $88.74 $136,672 - $148,195
-1,670 Reduced 7.78%
19,798 $1.66 Million
Q2 2019

Jul 09, 2019
BUY
$72.88 - $85.0 $29,152 - $34,000
400 Added 1.9%
21,468 $1.81 Million
Q1 2019

Apr 11, 2019
BUY
$66.22 - $80.06 $66,220 - $80,060
1,000 Added 4.98%
21,068 $1.68 Million
Q4 2018

Jan 15, 2019
BUY
$65.56 - $74.27 $69,493 - $78,726
1,060 Added 5.58%
20,068 $1.45 Million
Q3 2018

Oct 15, 2018
BUY
$60.81 - $73.36 $194,409 - $234,531
3,197 Added 20.22%
19,008 $1.39 Million
Q2 2018

Jul 12, 2018
BUY
$57.57 - $63.54 $145,939 - $161,073
2,535 Added 19.09%
15,811 $964,000
Q1 2018

Apr 18, 2018
BUY
$56.27 - $63.62 $197,507 - $223,306
3,510 Added 35.94%
13,276 $795,000
Q4 2017

Jan 16, 2018
BUY
$53.68 - $57.47 $81,056 - $86,779
1,510 Added 18.29%
9,766 $557,000
Q3 2017

Oct 17, 2017
BUY
$48.06 - $53.64 $396,783 - $442,851
8,256
8,256 $441,000

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track First United Bank & Trust Portfolio

Follow First United Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First United Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on First United Bank & Trust with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email